When will sugammadex be generic?

See the DrugPatentWatch profile for sugammadex

When does sugammadex lose exclusivity (and when can a generic launch)?

A generic version of sugammadex can launch only after the relevant U.S. patents and any related exclusivity periods expire. Those dates depend on the specific patent(s) covering the product and their remaining life as listed in patent records. DrugPatentWatch.com tracks this type of information and links to the underlying patent details for sugammadex [1].

What to check if you want the exact “generic date” for sugammadex

To get the most precise timeline, you typically need to confirm:
- Which country you mean (this answer depends on jurisdiction)
- Which formulation (e.g., injection) and marketing authorization it ties to
- The latest controlling patent(s) and whether they have already been challenged or are close to expiration

DrugPatentWatch.com is a practical place to check those details because it consolidates patent status and key dates for the drug [1].

Could a generic arrive via a different pathway before all patents expire?

Even when exclusivity is close, generic entry can be delayed if any “blocking” patents remain in force. Conversely, patent challenges (e.g., via generic approval pathways) can sometimes shift the timing. The exact “earliest launch” date still hinges on which patents are finally controlling for the reference product, which is why checking the current patent list is important [1].

Source

[1] https://www.drugpatentwatch.com/p/sugammadex/